This company has been marked as potentially delisted and may not be actively trading. Medicines (MDCO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock MDCO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period GSK’s Blenrep Receives Positive CHMP Opinion for Multiple Myeloma TreatmentMay 23 at 7:50 AM | tipranks.comSoleno Therapeutics' Marketing Authorization Application for Diazoxide Choline Tablets Validated by European Medicines Agency for Prader-Willi Syndrome TreatmentMay 22 at 6:16 PM | quiverquant.comBioArctic Gains EU Orphan Designation for MSA TreatmentMay 22 at 9:35 AM | tipranks.comFDA panel debates COVID vaccine recipe as questions swirl about fall shotsGovernment vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winterMay 22 at 8:54 AM | marketbeat.com4SC AG Faces Setback as EMA Signals Negative Opinion on ResminostatMay 20, 2025 | tipranks.comAlligator Bioscience Secures Pediatric Study Waiver for MitazalimabMay 20, 2025 | tipranks.comPraxis Precision Medicines to Participate in Upcoming ConferencesMay 20, 2025 | investing.comQuoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton SyndromeMay 20, 2025 | investing.comTYK Medicines Joins Hang Seng Biotech IndexMay 18, 2025 | tipranks.comRevolution Medicines (RVMD) Receives Adjusted Price Target from HC Wainwright | RVMD Stock NewsMay 14, 2025 | gurufocus.comRevolution Medicines (RVMD) Price Target Reduced by H.C. Wainwright Analyst | RVMD Stock NewsMay 14, 2025 | gurufocus.comRevolution Medicines Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating ...May 14, 2025 | gurufocus.comRevolution Medicines (RVMD) Initiates RASolve 301 Phase 3 Trial | RVMD Stock NewsMay 14, 2025 | gurufocus.comMoleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical TrialMay 12, 2025 | gurufocus.comMoleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial ...May 12, 2025 | gurufocus.comNovartis (NVS) Commits to Uninterrupted Production of Essential Medicines | NVS Stock NewsMay 12, 2025 | gurufocus.comRevolution Medicines: Strategic Advancements in NSCLC Treatment Drive Buy RatingMay 8, 2025 | tipranks.comDecoding Revolution Medicines Inc (RVMD): A Strategic SWOT InsightMay 8, 2025 | gurufocus.comInsider Sell: Christina Rossi Sells Shares of Blueprint Medicines Corp (BPMC)May 7, 2025 | gurufocus.comEverest Medicines’ NEFECON® Gains Full Approval in China for IgAN TreatmentMay 6, 2025 | tipranks.comIntensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Receive European Medicines Agency Authorization to Initiate Phase 2 INVINCIBLE-4 (SAKK/66/22) Study for INT230-6 in tMay 6, 2025 | investing.comTrump Orders FDA To Fast-Track US Drug Production As Tariff Threat Looms On Imported Medicines: Cites National Security ConcernsMay 6, 2025 | benzinga.comPraxis Precision Medicines: Advancements and Financial OutlookMay 6, 2025 | tipranks.comCautious Optimism: Blueprint Medicines’ Hold Rating Amid Mixed Growth SignalsMay 5, 2025 | tipranks.comPraxis Precision Medicines Shares Promising EMBOLD Study DataMay 2, 2025 | tipranks.comQ1 2025 Blueprint Medicines Corp Earnings Call TranscriptMay 2, 2025 | gurufocus.comGSK (GSK) Q1 2025 Earnings Beat Forecasts Amid Specialty Medicines GrowthApril 30, 2025 | gurufocus.comPositive Clinical Data and Competitive Efficacy Drive Buy Rating for Revolution Medicines’ ZoldonrasibApril 29, 2025 | tipranks.comRevolution Medicines (RVMD) Reports Promising Data for Zoldonrasib in Lung Cancer | RVMD Stock NewsApril 28, 2025 | gurufocus.comWhy Is Cancer Drug Developer Revolution Medicines Stock Trading Higher On Monday?April 28, 2025 | benzinga.com4SC AG Awaits EMA Decision on Resminostat AuthorizationApril 28, 2025 | tipranks.comApril 28, 2025 | gurufocus.comRevolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with ...April 27, 2025 | gurufocus.comRevolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with ...April 27, 2025 | gurufocus.comRevolution Medicines Inc (RVMD) Announces Promising Clinical Data for Zoldonrasib in Lung ...April 27, 2025 | gurufocus.comRevolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual MeetingApril 27, 2025 | investing.comRevolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual MeetingApril 27, 2025 | markets.businessinsider.comBlueprint Medicines to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 | ...April 25, 2025 | gurufocus.comBlueprint Medicines to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025April 25, 2025 | gurufocus.comBlueprint Medicines Corp (BPMC) Announces Upcoming First Quarter 2025 Financial Results ...April 25, 2025 | gurufocus.comJazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab in Treating Advanced ...April 25, 2025 | gurufocus.comHold Rating for Blueprint Medicines Amidst Near-Term Challenges and Revenue VariabilityApril 22, 2025 | tipranks.comEverest Medicines Gains Approval for Listing Rule ChangesApril 21, 2025 | tipranks.comKingworld Medicines Group Ltd. Announces 2024 AGM and Key ResolutionsApril 17, 2025 | tipranks.comBeiGene Ltd (ONC) to Announce Q1 2025 Financial Results Amidst Rebranding to BeOne Medicines | ...April 17, 2025 | gurufocus.comEXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused EntityApril 17, 2025 | benzinga.comEverest Medicines Announces Leadership Change and Clarifies ESOP DetailsApril 15, 2025 | tipranks.comInnovative Medicines and MedTech Strategies in 2023: Key Insights and Impacts | JNJ Stock NewsApril 15, 2025 | gurufocus.comKingworld Medicines Group Ltd. Adopts New Share Award SchemeApril 14, 2025 | tipranks.comNovartis Commits $23 Billion to U.S. Expansion, Eyes Full Domestic Production of Key MedicinesApril 11, 2025 | gurufocus.com Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Email Address MDCO Media Mentions By Week MDCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDCO News Sentiment▼0.000.73▲Average Medical News Sentiment MDCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDCO Articles This Week▼93▲MDCO Articles Average Week Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RPRX News Today CORT News Today JAZZ News Today PRGO News Today SUPN News Today PCRX News Today OMER News Today NKTR News Today ASMB News Today CPIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDCO) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Medicines Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MDCO Stock Free MDCO Stock Alerts